BMJ Open, 2020 BackgroundNeonatal jaundice (NNJ) is a frequent complication of glucose-6-phosphate dehydrogenase (G6PD) deficiency.ObjectivesTo estimate the prevalence of G6PD deficiency among neonates with jaundice and to assess mothers’ perception towards G6PD and ...
Zeinab A Kasemy +3 more
doaj +1 more source
Mediterranean Journal of Hematology and Infectious Diseases, 2020 Introduction: The aim of the study was to enumerate the clinical, hematological and molecular spectrum of G6PD deficiency in malaria endemic regions of south west Odisha.
Ravindra Kumar +7 more
doaj +1 more source
Correlation Between Glucose – 6 – Phosphate Dehydrogenase Deficiency Level and Some Haematological Parameters on Newborn Blood in Al-Anbar Governorate-Ramadi [PDF]
مجلة جامعة الانبار للعلوم الصرفة, 2012 This study aimed to determine the prevalence of Glucose-6-Phosphate Dehydrogenase (G6PD) deficiency in Al-Anbar Governorate-Ramadi and to study the different relationships between these cases and different haematological parameters values. In addition to
Sabri M. Hussain +3 more
doaj +1 more source
African glucose-6-phosphate dehydrogenase alleles associated with protection from severe malaria in heterozygous females in Tanzania [PDF]
, 2015 X-linked Glucose-6-phosphate dehydrogenase (G6PD) A- deficiency is prevalent in sub-Saharan Africa populations, and has been associated with protection from severe malaria.
,
core +7 more sources
Human G6PD variant structural studies: Elucidating the molecular basis of human G6PD deficiency [PDF]
, 2022 Glucose-6-phosphate dehydrogenase deficiency is by far the most prevalent human enzymopathy and is gener ated by a series of point mutations in the X-linked gene encoding G6PD.
Ab Latif, Nurriza +7 more
core +1 more source
Scientific Reports, 2021 Glucose-6-phosphate dehydrogenase (G6PD) deficiency is the most common enzymopathy in humans, affecting ~ 500 million worldwide. A detailed study of the structural stability and catalytic activity of G6PD variants is required to understand how different ...
Phonchanan Pakparnich +7 more
doaj +1 more source
Glucose-6-phosphate dehydrogenase deficiency in Nigerian children. [PDF]
PLoS ONE, 2013 Glucose-6-phosphate dehydrogenase (G6PD) deficiency is the most common human enzymopathy and in Sub-Saharan Africa, is a significant cause of infection- and drug-induced hemolysis and neonatal jaundice.
Olatundun Williams +5 more
doaj +1 more source
Clinical spectrum and severity of hemolytic anemia in glucose 6-phosphate dehydrogenase-deficient children receiving dapsone [PDF]
, 2012 Drug-induced acute hemolytic anemia led to the discovery of G6PD deficiency. However, most clinical data are from isolated case reports. In 2 clinical trials of antimalarial preparations containing dapsone (4,4′-diaminodiphenylsulfone; 2.5 mg/kg once ...
Pamba, Allan +6 more
core +4 more sources
PLoS ONE, 2023 Glucose-6-phosphate dehydrogenase (G6PD) deficiency is an X-linked enzymopathy caused by mutations in the G6PD gene. A medical concern associated with G6PD deficiency is acute hemolytic anemia induced by certain foods, drugs, and infections.
Kamonwan Chamchoy +8 more
doaj +1 more source
The First Case of a Class I Glucose-6-phosphate Dehydrogenase Deficiency, G6PD Santiago de Cuba (1339 GA), in a Chinese Population as Found in a Survey for G6PD Deficiency in Northeastern and Central China [PDF]
, 2010 In Liaoning Province in northeastern China, we found a G6PD-deficient patient at the age of 3. By the classification of the World Health Organization, this patient was categorized as class I (very severe G6PD deficiency).
Hirai, Makoto +5 more
core +1 more source